Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-05

Clinical Trial Update: Astragalus Membranaceus for Brain Edema Induced by Hemorrhagic Stroke [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Astragalus Membranaceus for brain edema after hemorrhagic stroke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Astragalus membranaceus (Astragalus membranaceus)

Snippet

Sponsor: China Medical University Hospital | Conditions: Stroke, Hemorrhagic Transformation Due to Acute Stroke | Phase 2 | Status: COMPLETED